{"count": 9, "results": [{"_id": "36147344", "pmid": 36147344, "pmcid": "PMC9486097", "title": "Literature review of the clinical characteristics of metformin-induced hepatotoxicity", "journal": "Front Pharmacol", "authors": ["Wang C", "Deng H", "Xu Y", "Liu Y"], "date": "2022-09-06T00:00:00Z", "doi": "10.3389/fphar.2022.969505", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "969505", "score": 50275.492, "text_hl": "The MeSH terms and keywords were the following: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, hypoglycemic agents, @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@hepatitis@@@, hepatotoxicity, @DISEASE_Jaundice @DISEASE_MESH:D007565 @@@jaundice@@@, @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver injury@@@, @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@, @DISEASE_Cholangitis @DISEASE_MESH:D002761 @@@cholangitis@@@, and @DISEASE_Cholestasis @DISEASE_MESH:D002779 @@@cholestasis@@@. ", "citations": {"NLM": "Wang C, Deng H, Xu Y, Liu Y. Literature review of the clinical characteristics of metformin-induced hepatotoxicity Front Pharmacol. 2022;13():969505. PMID: 36147344", "BibTeX": "@article{36147344, title={Literature review of the clinical characteristics of metformin-induced hepatotoxicity}, author={Wang C and Deng H and Xu Y and Liu Y}, journal={Front Pharmacol}, volume={13}, pages={969505}}"}}, {"_id": "39230880", "pmid": 39230880, "title": "Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia.", "journal": "JAMA Dermatol", "authors": ["Bao A", "Qadri A", "Gadre A", "Will E", "Collins D", "Ahima R", "Bordone LA", "Aguh C"], "date": "2024-09-04T00:00:00Z", "doi": "10.1001/jamadermatol.2024.3062", "meta_date_publication": "2024 Sep 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.23, "text_hl": "After at least 6 months of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment, 9 @SPECIES_9606 @@@participants@@@ experienced improvement in disease, including @DISEASE_Pain @DISEASE_MESH:D010146 @@@scalp pain@@@, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, and/or @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@, and 6 demonstrated clinical evidence of hair regrowth. ", "citations": {"NLM": "Bao A, Qadri A, Gadre A, Will E, Collins D, Ahima R, Bordone LA, Aguh C. Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia. JAMA Dermatol. 2024 Sep 4;():. PMID: 39230880", "BibTeX": "@article{39230880, title={Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia.}, author={Bao A and Qadri A and Gadre A and Will E and Collins D and Ahima R and Bordone LA and Aguh C}, journal={JAMA Dermatol}}"}}, {"_id": "31437844", "pmid": 31437844, "title": "Possible Involvement of Nitric Oxide in the Antipruritic Effect of Metformin on Chloroquine-Induced Scratching in Mice.", "journal": "Dermatology", "authors": ["Haddadi NS", "Shakiba S", "Afshari K", "Haj-Mirzaian A", "Vesaghati S", "Gharagozlou S", "Foroumadi R", "Shafaroodi H", "Ostadhadi S", "Dehpour AR"], "date": "2020-01-01T00:00:00Z", "doi": "10.1159/000501583", "meta_date_publication": "2020", "meta_volume": "236", "meta_issue": "2", "meta_pages": "151-159", "score": 50248.67, "text_hl": "...BACKGROUND: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates non-@CHEMICAL_Histamine @CHEMICAL_MESH:D006632 @@@histamine@@@-mediated @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@itch@@@. ", "citations": {"NLM": "Haddadi NS, Shakiba S, Afshari K, Haj-Mirzaian A, Vesaghati S, Gharagozlou S, Foroumadi R, Shafaroodi H, Ostadhadi S, Dehpour AR. Possible Involvement of Nitric Oxide in the Antipruritic Effect of Metformin on Chloroquine-Induced Scratching in Mice. Dermatology. 2020;236(2):151-159. PMID: 31437844", "BibTeX": "@article{31437844, title={Possible Involvement of Nitric Oxide in the Antipruritic Effect of Metformin on Chloroquine-Induced Scratching in Mice.}, author={Haddadi NS and Shakiba S and Afshari K and Haj-Mirzaian A and Vesaghati S and Gharagozlou S and Foroumadi R and Shafaroodi H and Ostadhadi S and Dehpour AR}, journal={Dermatology}, volume={236}, number={2}, pages={151-159}}"}}, {"_id": "35220243", "pmid": 35220243, "title": "Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?", "journal": "Anticancer Res", "authors": ["Ciccarese C", "Iacovelli R", "Buti S", "Primi F", "Astore S", "Massari F", "Ferrara MG", "Palermo G", "Foschi N", "Iacovelli V", "Rossi E", "Schinzari G", "Bove P", "Bassi P", "Bria E", "Tortora G"], "date": "2022-03-01T00:00:00Z", "doi": "10.21873/anticanres.15620", "meta_date_publication": "2022 Mar", "meta_volume": "42", "meta_issue": "3", "meta_pages": "1487-1493", "score": 50247.32, "text_hl": "The concomitant use of @CHEMICAL_Nivolumab @CHEMICAL_MESH:D000077594 @@@nivolumab@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was well tolerated; adverse events (AEs) of any grade occurred in 75% of @SPECIES_9606 @@@patients@@@ (mainly @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@, @DISEASE_Exanthema @DISEASE_MESH:D005076 @@@rash@@@, and @DISEASE_Asthenia @DISEASE_MESH:D001247 @@@asthenia@@@). ", "citations": {"NLM": "Ciccarese C, Iacovelli R, Buti S, Primi F, Astore S, Massari F, Ferrara MG, Palermo G, Foschi N, Iacovelli V, Rossi E, Schinzari G, Bove P, Bassi P, Bria E, Tortora G. Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active? Anticancer Res. 2022 Mar;42(3):1487-1493. PMID: 35220243", "BibTeX": "@article{35220243, title={Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?}, author={Ciccarese C and Iacovelli R and Buti S and Primi F and Astore S and Massari F and Ferrara MG and Palermo G and Foschi N and Iacovelli V and Rossi E and Schinzari G and Bove P and Bassi P and Bria E and Tortora G}, journal={Anticancer Res}, volume={42}, number={3}, pages={1487-1493}}"}}, {"_id": "37822304", "pmid": 37822304, "pmcid": "PMC10564254", "title": "Recurrent early-onset severe obstetric cholestasis in a patient with two variants in the ABCB4 gene", "journal": "Hepatol Forum", "authors": ["Khattak MF", "Thomson S"], "date": "2023-09-20T00:00:00Z", "doi": "10.14744/hf.2023.2023.0008", "meta_date_publication": "2023", "meta_volume": "4", "meta_issue": "3", "meta_pages": "142-144", "score": 50228.887, "text_hl": "These blood results were not repeated or followed up on; however, the @SPECIES_9606 @@@patient@@@ reports spontaneous resolution of her @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@.", "citations": {"NLM": "Khattak MF, Thomson S. Recurrent early-onset severe obstetric cholestasis in a patient with two variants in the ABCB4 gene Hepatol Forum. 2023;4(3):142-144. PMID: 37822304", "BibTeX": "@article{37822304, title={Recurrent early-onset severe obstetric cholestasis in a patient with two variants in the ABCB4 gene}, author={Khattak MF and Thomson S}, journal={Hepatol Forum}, volume={4}, number={3}, pages={142-144}}"}}, {"_id": "25906350", "pmid": 25906350, "title": "Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice.", "journal": "Pain", "authors": ["Obara I", "Medrano MC", "Signoret-Genest J", "Jiménez-Díaz L", "Géranton SM", "Hunt SP"], "date": "2015-08-01T00:00:00Z", "doi": "10.1097/j.pain.0000000000000197", "meta_date_publication": "2015 Aug", "meta_volume": "156", "meta_issue": "8", "meta_pages": "1519-1529", "score": 50059.73, "text_hl": "The actions of the antidiabetic drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in ameliorating nonhistamine-mediated @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@itch@@@ also suggest a new therapeutic route for the control of this category of @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@. ", "citations": {"NLM": "Obara I, Medrano MC, Signoret-Genest J, Jiménez-Díaz L, Géranton SM, Hunt SP. Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice. Pain. 2015 Aug;156(8):1519-1529. PMID: 25906350", "BibTeX": "@article{25906350, title={Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice.}, author={Obara I and Medrano MC and Signoret-Genest J and Jiménez-Díaz L and Géranton SM and Hunt SP}, journal={Pain}, volume={156}, number={8}, pages={1519-1529}}"}}, {"_id": "14561576", "pmid": 14561576, "title": "Metformin-induced cholestatic hepatitis.", "journal": "Endocr Pract", "authors": ["Nammour FE", "Fayad NF", "Peikin SR"], "date": "2003-07-01T00:00:00Z", "doi": "10.4158/EP.9.4.307", "meta_date_publication": "2003 Jul-Aug", "meta_volume": "9", "meta_issue": "4", "meta_pages": "307-9", "score": 50058.28, "text_hl": "The dosage initially was 500 mg twice daily and later was increased to 850 mg twice a day. Four weeks after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@met-formin@@@ treatment was initiated, @DISEASE_Jaundice @DISEASE_MESH:D007565 @@@jaundice@@@, @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@, and @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@liver enzyme abnormalities@@@ were noted. ", "citations": {"NLM": "Nammour FE, Fayad NF, Peikin SR. Metformin-induced cholestatic hepatitis. Endocr Pract. 2003 Jul-Aug;9(4):307-9. PMID: 14561576", "BibTeX": "@article{14561576, title={Metformin-induced cholestatic hepatitis.}, author={Nammour FE and Fayad NF and Peikin SR}, journal={Endocr Pract}, volume={9}, number={4}, pages={307-9}}"}}, {"_id": "27048192", "pmid": 27048192, "title": "Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?", "journal": "Curr Drug Saf", "authors": ["Vasapollo P", "Cione E", "Luciani F", "Gallelli L"], "date": "2018-01-01T00:00:00Z", "doi": "10.2174/1574886311666160405110515", "meta_date_publication": "2018", "meta_volume": "13", "meta_issue": "1", "meta_pages": "38-40", "score": 50057.746, "text_hl": "Clinical and laboratory findings excluded the presence of systemic or @DISEASE_Skin_Diseases @DISEASE_MESH:D012871 @@@skin diseases@@@ able to induce @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@. The discontinuation of @CHEMICAL_Canagliflozin @CHEMICAL_MESH:D000068896 @@@canagliflozin@@@ and the treatment with @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@/@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ fixed combination induced a remission of @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@. ", "citations": {"NLM": "Vasapollo P, Cione E, Luciani F, Gallelli L. Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction? Curr Drug Saf. 2018;13(1):38-40. PMID: 27048192", "BibTeX": "@article{27048192, title={Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?}, author={Vasapollo P and Cione E and Luciani F and Gallelli L}, journal={Curr Drug Saf}, volume={13}, number={1}, pages={38-40}}"}}, {"_id": "27574928", "pmid": 27574928, "title": "DRESS Syndrome Following Metformin Administration: A Case Report and Review of the Literature.", "journal": "Am J Ther", "authors": ["Voore P", "Odigwe C", "Mirrakhimov AE", "Rifai D", "Iroegbu NA"], "date": "2016-11-01T00:00:00Z", "doi": "10.1097/MJT.0000000000000292", "meta_date_publication": "2016 Nov/Dec", "meta_volume": "23", "meta_issue": "6", "meta_pages": "e1970-e1973", "score": 50053.62, "text_hl": "We report a case of this syndrome in a 40-year-old man presenting with a @DISEASE_Exanthema @DISEASE_MESH:D005076 @@@rash@@@, generalized @<m>DISEASE_Pruritus</m> @DISEASE_MESH:D011537 @@@pruritus@@@, @DISEASE_Lymphatic_Diseases @DISEASE_MESH:D008206 @@@lymphadenopathy@@@, and @DISEASE_Eosinophilia @DISEASE_MESH:D004802 @@@eosinophilia@@@ after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. ", "citations": {"NLM": "Voore P, Odigwe C, Mirrakhimov AE, Rifai D, Iroegbu NA. DRESS Syndrome Following Metformin Administration: A Case Report and Review of the Literature. Am J Ther. 2016 Nov/Dec;23(6):e1970-e1973. PMID: 27574928", "BibTeX": "@article{27574928, title={DRESS Syndrome Following Metformin Administration: A Case Report and Review of the Literature.}, author={Voore P and Odigwe C and Mirrakhimov AE and Rifai D and Iroegbu NA}, journal={Am J Ther}, volume={23}, number={6}, pages={e1970-e1973}}"}}]}